China's loss is India's gain as Western drug makers pivot &#

Pharmaceutical companies are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing, industry insiders said.

Related Keywords

China , India , United States , Shanghai , Chinese , Indian Cdmos , Ramesh Subramanian , Peter Deyoung , Piramal Pharma , Ashish Nimgaonkar , Helen Chen , Tommy Erdei , Piramal Pharma Solutions , Aragen Life Sciences , Sai Life Sciences , Drug Administration , Glyscend Therapeutics , Greater China Managing Partner , Mordor Intelligence , Life Sciences ,